SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-13-390203
Filing Date
2013-10-03
Accepted
2013-10-03 16:01:37
Documents
9

Document Format Files

Seq Description Document Type Size
1 SC 13D d605546dsc13d.htm SC 13D 65515
2 EX-3 d605546dex3.htm EX-3 92988
3 EX-4 d605546dex4.htm EX-4 217023
4 EX-5 d605546dex5.htm EX-5 176601
5 EX-99.6 d605546dex996.htm EX-99.6 162636
6 EX-7 d605546dex7.htm EX-7 37785
7 GRAPHIC g605546g29t16.jpg GRAPHIC 21365
8 GRAPHIC g605546g74e53.jpg GRAPHIC 42902
9 GRAPHIC g605546g88n24.jpg GRAPHIC 33160
  Complete submission text file 0001193125-13-390203.txt   888722
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filed by) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address 128 SYDNEY STREET CAMBRIDGE MA 02139
Business Address 128 SYDNEY STREET CAMBRIDGE MA 02139 617-649-9200
ACCELERON PHARMA INC (Subject) CIK: 0001280600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87630 | Film No.: 131133751
SIC: 2836 Biological Products, (No Diagnostic Substances)